Hemophagocytic Lymphohistiocytosis and Miliary Tuberculosis in an Apparently Immunocompetent Patient: A Case Report.

hemophagocytic lymphoistiocytosis paradoxical reaction tuberculosis

Journal

Infectious disease reports
ISSN: 2036-7430
Titre abrégé: Infect Dis Rep
Pays: Switzerland
ID NLM: 101537203

Informations de publication

Date de publication:
17 Aug 2024
Historique:
received: 19 07 2024
revised: 08 08 2024
accepted: 15 08 2024
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 28 8 2024
Statut: epublish

Résumé

Hemophagocytic lymphohistiocytosis (HLH) is a serious haematologic condition that can be related to various diseases, including tuberculosis (TB). The patient is a previously healthy 26-year-old man, originally from western Africa, admitted to hospital for fever and weight loss. Given the results of a computed tomography (CT) scan, ocular examination and microbiologic tests, miliary TB with pulmonary, lymph nodal and ocular involvement was diagnosed. Following the introduction of antitubercular treatment (ATT), an increase in inflammation indexes and severe pancytopenia were observed; at this point, the patient presented with six of the eight diagnostic criteria for HLH, and a diagnosis of HLH secondary to TB was raised. Therefore, HLH treatment with a high dose of dexamethasone was started, with a good clinical response. We performed a literature review of TB-related HLH, which shows a high mortality rate. ATT is necessary to ensure patient survival to remove the antigenic driver. Our patient developed HLH after the initiation of ATT as a paradoxical reaction, which may be linked to the release of antigens due to the bactericidal effect of ATT.

Identifiants

pubmed: 39195009
pii: idr16040058
doi: 10.3390/idr16040058
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

763-769

Auteurs

Filippo Ducci (F)

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.

Francesca Mariotti (F)

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.

Jessica Mencarini (J)

Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy.

Claudio Fabbri (C)

Unit of Infectious Diseases, San Jacopo Hospital, Azienda ASL Toscana Centro, 51100 Pistoia Pe, Italy.

Alessandra Francesca Manunta (AF)

Unit of Infectious Diseases, San Jacopo Hospital, Azienda ASL Toscana Centro, 51100 Pistoia Pe, Italy.

Daniela Messeri (D)

Unit of Infectious Diseases, San Jacopo Hospital, Azienda ASL Toscana Centro, 51100 Pistoia Pe, Italy.

Paola Parronchi (P)

Immunology and Cellular Therapies Unit, Careggi University Hospital, 50134 Florence, Italy.

Pierluigi Blanc (P)

Unit of Infectious Diseases, San Jacopo Hospital, Azienda ASL Toscana Centro, 51100 Pistoia Pe, Italy.

Alessandro Bartoloni (A)

Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.
Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy.

Classifications MeSH